Optimize Clinical Trial Success by Reducing the Number of Patients Lost to Follow-Up

The ultimate success of any clinical trial depends upon the timely submission of complete and accurate data. When study subjects drop out of a trial, your data’s integrity is compromised resulting in the “tombstone” press release; the one that states, “While the data from the trial showed ‘positive trends,’ the results were not statistically significant and the endpoints were not met.” Moreover, replacing lost patients costs money and delays your clinical trial endpoint.

Download this brochure and learn more about Bioclinica’s Lost to Follow-Up service (L2FU™) and our dedication to reducing the number of patients lost.